
GEBR-7b
CAS No. 67387-76-2
GEBR-7b( 3-(Cyclopentyloxy)-4-methoxybenzaldehyde )
Catalog No. M27181 CAS No. 67387-76-2
GEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
![]() ![]() |
10MG | 68 | In Stock |
![]() ![]() |
25MG | 115 | In Stock |
![]() ![]() |
50MG | 173 | In Stock |
![]() ![]() |
100MG | 258 | In Stock |
![]() ![]() |
200MG | 388 | In Stock |
![]() ![]() |
500MG | 642 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameGEBR-7b
-
NoteResearch use only, not for human use.
-
Brief DescriptionGEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
-
DescriptionGEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms3-(Cyclopentyloxy)-4-methoxybenzaldehyde
-
PathwayAngiogenesis
-
TargetPDE
-
Recptorhuman HEPG2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67387-76-2
-
Formula Weight220.268
-
Molecular FormulaC13H16O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(C=O)cc1OC1CCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Joerg Kley, et al. Sulfonamides as inhibitors of the uptake of extracellular citrate. Patent WO2018104220A1
molnova catalog



related products
-
Mirodenafil dihydroc...
Mirodenafil dihydrochloride is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.
-
GSK 356278
A potent, selective, brain-penetrant and orally bioavailable phosphodiesterase 4 (PDE4) inhibitor with pIC50 of 8.8 (PDE4B); equally inhibits PDE4A and PDE4Dwith pIC50 of 8.6 and 8.7.
-
ATX inhibitor 5
ATX inhibitor 5 is a potent and orally active autotaxin (ATX) inhibitor (IC50: 15.3 nM) that reduces CCl4-induced hepatic fibrosis and exhibits anti-hepatic fibrosis effects.